TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -6.40%2.56B | ---- | 49.10%2.74B | ---- | -37.73%1.84B | ---- | 38.74%2.95B | ---- | 32.47%2.13B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -80.46%-568.33M | ---- | -44.33%-314.93M | ---- | -58.20%-218.2M | ---- | -48.17%-137.93M | ---- | -195.96%-93.09M |
Dividend (income)- adjustment | ---- | 20.97%-7.66M | ---- | 10.93%-9.69M | ---- | -8.73%-10.88M | ---- | -103.92%-10.01M | ---- | 3,740.76%255.04M |
Attributable subsidiary (profit) loss | ---- | -7.73%835K | ---- | -66.91%905K | ---- | 252.45%2.74M | ---- | 205.51%776K | ---- | 108.13%254K |
Impairment and provisions: | ---- | 64.56%394.04M | ---- | 89.52%239.45M | ---- | 791.09%126.35M | ---- | -74.51%14.18M | ---- | 78.61%55.63M |
-Impairmen of inventory (reversal) | ---- | 251.28%338.6M | ---- | 647.92%96.39M | ---- | 166.78%12.89M | ---- | -79.07%4.83M | ---- | 183.63%23.08M |
-Other impairments and provisions | ---- | -61.25%55.44M | ---- | 26.09%143.06M | ---- | 1,113.72%113.46M | ---- | -71.28%9.35M | ---- | 41.46%32.55M |
Revaluation surplus: | ---- | 107.71%3.36M | ---- | -499.42%-43.63M | ---- | -14.36%-7.28M | ---- | 38.99%-6.36M | ---- | -189.42%-10.43M |
-Derivative financial instruments fair value (increase) | ---- | 71.32%-16.94M | ---- | -176.62%-59.06M | ---- | -181.19%-21.35M | ---- | 1,041.49%26.3M | ---- | 8.17%2.3M |
-Other fair value changes | ---- | 31.51%20.3M | ---- | 9.69%15.44M | ---- | 143.09%14.07M | ---- | -156.49%-32.66M | ---- | -233.56%-12.74M |
Asset sale loss (gain): | ---- | 320.14%55.17M | ---- | -71.44%13.13M | ---- | --45.99M | ---- | ---- | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---53.33M | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -16.99%55.17M | ---- | 44.53%66.46M | ---- | --45.99M | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | 7.91%786.7M | ---- | 31.02%729.05M | ---- | 13.68%556.45M | ---- | 9.07%489.48M | ---- | 13.91%448.78M |
-Other depreciation and amortization | ---- | -100.79%-80.54M | ---- | 13.03%-40.11M | ---- | -16.00%-46.12M | ---- | -22.88%-39.76M | ---- | -606.37%-32.36M |
Financial expense | ---- | 41.69%482.78M | ---- | 34.10%340.74M | ---- | 19.78%254.09M | ---- | 1,647.84%212.13M | ---- | ---13.71M |
Exchange Loss (gain) | ---- | -75.20%33.14M | ---- | 5,025.51%133.63M | ---- | ---2.71M | ---- | ---- | ---- | ---- |
Special items | ---- | 81.82%-10.86M | ---- | 0.37%-59.74M | ---- | -693.41%-59.96M | ---- | -37.92%10.1M | ---- | 120.45%16.28M |
Operating profit before the change of operating capital | ---- | -0.93%3.73B | ---- | 49.31%3.77B | ---- | -28.35%2.52B | ---- | 26.48%3.52B | ---- | 28.09%2.78B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 87.57%-305.61M | ---- | -21,078.48%-2.46B | ---- | 98.44%-11.61M | ---- | 5.94%-743.77M | ---- | 17.66%-790.74M |
Developing property (increase)decrease | ---- | -39.31%-305.36M | ---- | 42.09%-219.19M | ---- | 2.87%-378.49M | ---- | -29.77%-389.7M | ---- | ---300.3M |
Accounts receivable (increase)decrease | ---- | 97.14%-51.31M | ---- | -71.41%-1.79B | ---- | -30.53%-1.05B | ---- | -15,545.26%-801.92M | ---- | -98.98%5.19M |
Accounts payable increase (decrease) | ---- | -100.89%-25.32M | ---- | 94.03%2.85B | ---- | 111.44%1.47B | ---- | -24.01%693.71M | ---- | 682.31%912.87M |
Special items for working capital changes | ---- | 69.14%637.85M | ---- | 0.66%377.12M | ---- | 28.55%374.63M | ---- | 347.33%291.43M | ---- | -119.27%-117.83M |
Cash from business operations | ---- | 46.25%3.68B | ---- | -14.00%2.52B | ---- | 13.85%2.93B | ---- | 3.12%2.57B | ---- | 1.82%2.49B |
Other taxs | ---- | 23.67%-449.87M | ---- | -2.88%-589.36M | ---- | -114.45%-572.86M | ---- | 47.57%-267.13M | ---- | -168.70%-509.46M |
Interest paid - operating | ---- | -166.30%-903.53M | ---- | -35.41%-339.29M | ---- | -23.46%-250.56M | ---- | 17.50%-202.94M | ---- | -34.71%-246M |
Special items of business | -110.56%-161.61M | ---- | 427.27%1.53B | ---- | 78.60%-467.69M | ---- | -213.60%-2.19B | ---- | 136.78%1.92B | ---- |
Net cash from operations | -110.56%-161.61M | 46.56%2.33B | 427.27%1.53B | -24.47%1.59B | 78.60%-467.69M | 0.13%2.1B | -213.60%-2.19B | 20.90%2.1B | 136.78%1.92B | -16.30%1.74B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 7.79%296.84M | 80.46%568.33M | 125.83%275.4M | 72.52%314.93M | 31.43%121.95M | 52.78%182.55M | 84.40%92.78M | 28.73%119.48M | 27.05%50.32M | 195.08%92.82M |
Dividend received - investment | ---- | -20.97%7.66M | ---- | -10.93%9.69M | ---- | 8.73%10.88M | ---- | 33.91%10.01M | ---- | -24.74%7.47M |
Loan receivable (increase) decrease | 45.81%614.78M | 79.67%-149.21M | 250.28%421.65M | -120.65%-733.82M | 139.14%120.38M | -60.42%-332.57M | -41.25%-307.53M | ---207.31M | ---217.72M | ---- |
Decrease in deposits (increase) | -844.71%-3.72B | 75.43%-598.94M | -6.77%-393.55M | -48.63%-2.44B | 19.11%-368.61M | -550.58%-1.64B | -51.84%-455.67M | 195.85%363.98M | 73.04%-300.09M | 136.09%123.03M |
Sale of fixed assets | 458.23%23.78M | 31.79%57.69M | -25.24%4.26M | -32.77%43.78M | -36.60%5.7M | 106.43%65.12M | -93.40%8.99M | 62.46%31.55M | 1,717.13%136.09M | -27.74%19.42M |
Purchase of fixed assets | 27.99%-1.4B | -22.31%-3.57B | -38.70%-1.95B | -44.09%-2.92B | -64.98%-1.4B | -77.52%-2.03B | -5.05%-851.63M | 1.35%-1.14B | -41.59%-810.7M | -81.42%-1.16B |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --9.37M | ---- |
Purchase of intangible assets | ---- | -38.10%-146.92M | ---- | 67.49%-106.39M | ---- | -103.17%-327.27M | ---- | -153.56%-161.08M | 27.10%-13.1M | ---63.53M |
Sale of subsidiaries | ---67.06M | -51.42%31.1M | ---- | --64.02M | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | --16.63M | ---- | ---- | ---- | ---161.91M | ---- | ---- |
Recovery of cash from investments | 13.92%2.31B | -69.53%3.13B | -64.54%2.03B | -23.44%10.26B | 20.35%5.71B | 1,634.78%13.4B | 9,311.20%4.75B | 6,010.54%772.56M | ---51.54M | -99.93%12.64M |
Cash on investment | 10.96%-2.53B | 64.33%-3.21B | 59.75%-2.84B | 37.61%-8.99B | -7.49%-7.07B | -1,600.54%-14.41B | -209,771.82%-6.58B | -4,012.26%-847.5M | 74.67%-3.13M | 99.90%-20.61M |
Other items in the investment business | -44.44%66.08M | 14.64%310.03M | -16.07%118.94M | 105.94%270.44M | 37.15%141.71M | 6.11%131.32M | 643.71%103.32M | 19.70%123.76M | -60.61%13.89M | 144.21%103.39M |
Net cash from investment operations | -88.47%-4.41B | 15.08%-3.58B | 14.53%-2.34B | 14.90%-4.21B | 15.42%-2.74B | -350.21%-4.95B | -172.87%-3.24B | -24.38%-1.1B | 27.35%-1.19B | 58.23%-883.68M |
Net cash before financing | -464.49%-4.57B | 52.45%-1.25B | 74.73%-810.16M | 7.81%-2.62B | 40.87%-3.21B | -383.62%-2.84B | -835.79%-5.42B | 17.29%1B | 189.77%737.04M | 2,315.81%854.84M |
Cash flow from financing activities | ||||||||||
New borrowing | 14.50%10.29B | 69.27%13.47B | 80.14%8.99B | -2.66%7.96B | -5.30%4.99B | 48.56%8.17B | 28.77%5.27B | 2.73%5.5B | 1.15%4.09B | 34.76%5.36B |
Refund | -30.07%-5.07B | -72.07%-10.6B | -127.86%-3.9B | -11.44%-6.16B | -98.91%-1.71B | 4.62%-5.53B | 71.34%-860.06M | 5.75%-5.8B | 5.55%-3B | -75.57%-6.15B |
Issuing shares | ---- | --972.05M | ---- | ---- | ---- | --4.73B | --4.73B | ---- | ---- | ---- |
Dividends paid - financing | 65.10%-90.33M | -67.75%-670.9M | -151.18%-258.82M | 12.84%-399.95M | -31.19%-103.04M | 0.65%-458.85M | 72.96%-78.54M | -21.84%-461.84M | -9.19%-290.45M | 2.75%-379.04M |
Absorb investment income | ---- | -98.48%1.47M | -98.27%1.55M | -46.49%96.51M | -50.02%89.22M | 154.95%180.35M | 166.42%178.5M | -87.29%70.74M | 36.73%67M | 1,035.60%556.44M |
Issuance expenses and redemption of securities expenses | ---1.12M | ---- | ---- | ---- | ---- | ---- | 45.86%-2.65M | ---4.89M | ---4.89M | ---- |
Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---15M |
Other items of the financing business | ---210M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -101.34%-1.44M | 183.41%105.57M |
Net cash from financing operations | 1.88%4.91B | 114.70%3.16B | 48.10%4.82B | -79.25%1.47B | -64.74%3.26B | 1,111.33%7.08B | 980.01%9.23B | -31.09%-700.55M | -8.46%855.07M | -861,832.26%-534.4M |
Net Cash | -91.53%339.84M | 265.84%1.91B | 7,949.72%4.01B | -127.15%-1.15B | -98.69%49.85M | 1,303.79%4.24B | 139.41%3.81B | -5.72%302.11M | 1,307.93%1.59B | 929.27%320.44M |
Begining period cash | 25.31%9.46B | -13.24%7.55B | -13.24%7.55B | 95.17%8.7B | 95.17%8.7B | 7.27%4.46B | 7.27%4.46B | 8.36%4.15B | 8.36%4.15B | -1.00%3.83B |
Cash at the end | -15.25%9.8B | 25.31%9.46B | 32.14%11.56B | -13.24%7.55B | 5.80%8.75B | 95.17%8.7B | 43.88%8.27B | 7.27%4.46B | 45.59%5.75B | 8.36%4.15B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.